Medtech InsightMedical Device Acquisitions The third quarter featured 21 device M&A transactions, 10 of which had disclosed values that together totaled $7.1bn, versus the second quarter, when 14 deals totaled $2bn.
Medtech InsightRight now, it appears COVID-19 diagnostics are holding up against new variants of the virus being detected. But that may not always be the case, scientists said at a 26 February webinar organized by
Medtech InsightAgena Bioscience is ready to make its mark on the liquid biopsy landscape with two new lung and colon cancer test panels. The CE-IVD marked panels incorporate Agena's UltraSEEK chemistry for mutatio
Medtech InsightFor years, mass spectrometry has been a key point of conversation during the annual AACC meetings, but it was an especially hot topic in 2014. That year, both SCIEX and Thermo Fisher Scientific In